Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma

PloS One
Zai AhmadLouis Chesler

Abstract

Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While the pathways that are deregulated in MB remain to be fully characterized, amplification and/or overexpression of the MYCN gene, which is has a critical role in cerebellar development as a regulator of neural progenitor cell fate, has been identified in several MB subgroups. Phenotypically, aberrant expression of MYCN is associated with the large-cell/anaplastic MB variant, which accounts for 5-15% of cases and is associated with aggressive disease and poor clinical outcome. To better understand the role of MYCN in MB in vitro and in vivo and to aid the development of MYCN-targeted therapeutics we established tumor-derived neurosphere cell lines from the GTML (Glt1-tTA/TRE-MYCN-Luc) genetically engineered mouse model. A fraction of GTML neurospheres were found to be growth factor independent, expressed CD133 (a marker of neural stem cells), failed to differentiate upon MYCN withdrawal and were highly tumorigenic when orthotopically implanted into the cerebellum. Principal component analyzes using single cell RNA assay data suggested that the clinical candidate aurora-A kinase inhibitor MLN8237 converts GTML neurospheres to resemble non-MYCN expressors...Continue Reading

References

Jun 2, 1997·The EMBO Journal·W A WeissJ M Bishop
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A Lim, A Alvarez-Buylla
Oct 4, 2000·Physiological Genomics·E M MichielsF Baas
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·N UchidaI L Weissman
Aug 11, 2001·Lancet·Y MarieK Hoang-Xuan
Jun 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Trudy G OliverRobert J Wechsler-Reya
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Houman D HemmatiHarley I Kornblum
Jan 13, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Erwin PauwsCarrie Ris-Stalpers
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan PfisterAndrey Korshunov
Jun 3, 2009·Cancer Research·Ryan J WardPeter B Dirks
May 19, 2010·Genes & Development·Fredrik J SwartlingLouis Chesler
Mar 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michelle MonjePaul G Fisher
Dec 3, 2011·Acta Neuropathologica·Michael D TaylorStefan M Pfister
Dec 14, 2011·Acta Neuropathologica·Andrey KorshunovStefan M Pfister
Feb 22, 2012·Cancer Cell·Charles G Eberhart
Feb 22, 2012·Cancer Cell·Yanxin PeiRobert J Wechsler-Reya
Feb 22, 2012·Cancer Cell·Daisuke KawauchiMartine F Roussel
Jun 23, 2012·Nature·Giles RobinsonRichard J Gilbertson
Jul 17, 2012·Cancer Letters·Branavan ManoranjanSheila K Singh
Jul 27, 2012·Nature·Paul A NorthcottMichael D Taylor
Jul 27, 2012·Nature·David T W JonesPeter Lichter
May 8, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ping MaoIchiro Nakano
Nov 5, 2013·Cold Spring Harbor Perspectives in Medicine·Martine F Roussel, Giles W Robinson
May 30, 2014·Acta Neuropathologica·Julia PöschlUlrich Schüller
Aug 12, 2014·Cancer Research·James R Van BrocklynNorman L Lehman

❮ Previous
Next ❯

Citations

Mar 31, 2017·Genes·María Victoria Ruiz-PérezMarie Arsenian-Henriksson
Feb 9, 2020·Journal of Clinical Pathology·Hisham F Bahmad, Robert J Poppiti
May 14, 2016·Cancer Science·Guo-Hao HuangSheng-Qing Lv
Mar 24, 2017·Genes·Sonja HutterFredrik J Swartling
Apr 5, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tamara J Abou-AntounStephen M Dombrowski
Jun 13, 2020·Frontiers in Cell and Developmental Biology·Pietro Laneve, Elisa Caffarelli
Feb 22, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mari KogisoXiao-Nan Li
Feb 16, 2021·Frontiers in Oncology·Anna BorgenvikFredrik J Swartling

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence-activated cell analyzer
FACS
PCR
transgenic
flow cytometry
PCA

Software Mentioned

R

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis